X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
    • ADventures
    • Data Dive
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Commodities
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Polling Explorer
    • Live: Trump's First 100 Days
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Media
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Life
    • Health
    • Sports
    • Arts
    • Entertainment
    • Oddly Enough
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
U.N. experts find weed killer glyphosate unlikely to cause cancer
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Health News | Mon May 16, 2016 | 11:54am EDT

U.N. experts find weed killer glyphosate unlikely to cause cancer

File photo of Monsanto's Roundup weedkiller atomizers seen on sale at a garden shop at Bonneuil-Sur-Marne near Paris, France, June 16, 2015.   REUTERS/Charles Platiau/Files
File photo of Monsanto's Roundup weedkiller atomizers seen on sale at a garden shop at Bonneuil-Sur-Marne near Paris, France, June 16, 2015. REUTERS/Charles Platiau/Files
By Kate Kelland, Health and Science Correspondent | LONDON

LONDON May 16 The pesticide glyphosate, sold by Monsanto in its Roundup weed killer product and widely used in agriculture and by gardeners, is unlikely to cause cancer in people, according to a new safety review by United Nations health, agriculture and food experts.

In a statement likely to intensify a row over its potential health impact, experts from the U.N.'s Food and Agriculture Organization (FAO) and World Health Organization (WHO) said glyphosate is "unlikely to pose a carcinogenic risk to humans" exposed to it through food. It is mostly used on crops.

Having reviewed the scientific evidence, the joint WHO/FAO committee also said glyphosate is unlikely to be genotoxic in humans. In other words, it is not likely to have a destructive effect on cells' genetic material.

Diazinon and malathion, two other pesticides reviewed by the committee, which met last week and published its conclusions on Monday, were also found to be unlikely to be carcinogenic.

"In view of the absence of carcinogenic potential in rodents at human-relevant doses and the absence of genotoxicity by the oral route in mammals, and considering the epidemiological evidence from occupational exposures, the meeting concluded that glyphosate is unlikely to pose a carcinogenic risk to humans from exposure through the diet," the committee said.

Glyphosate is also "unlikely to be genotoxic at anticipated dietary exposures", it added.

The group reaffirmed an acceptable daily intake (ADI) of up to 1 milligram of glyphosate for every kilogram of body weight.

CONTRADICTORY?

The conclusions appear to contradict a finding by the WHO's Lyon-based International Agency for Research on Cancer (IARC), which in March 2015 said glyphosate is "probably" able to cause cancer in humans and classified it as a 'Group 2A' carcinogen.

Seven months after the IARC review, the European Food Safety Authority (EFSA), an independent agency funded by the European Union, published a different assessment, saying glyphosate is "unlikely to pose a carcinogenic hazard to humans".

The United States' Environmental Protection Agency (EPA), which first assessed glyphosate in 1986 and has reviewed it several times since then, had also previously concluded it has "low toxicity for humans".

The differing findings thrust glyphosate into the centre of a row involving EU and U.S. politicians and regulators, the IARC experts, the WHO and environmental and agricultural scientists.

The EU's pesticides committee is due to meet later this week to decide whether to re-license glyphosate. The U.S. EPA is being investigated for withdrawing a report saying the chemical is probably not carcinogenic.

In a question-and-answer document issued alongside the joint FAO/WHO statement, the WHO denied that the conclusions by the joint group and by IARC were contradictory. It said they were "different, yet complementary", with the IARC assessment focussed on hazard while the other looked at risk.

"IARC reviews published studies to identify potential cancer hazards," the WHO said. "It does not estimate the level of risk to the population associated with exposure to the hazard."

In contrast, it said, the joint FAO/WHO committee looks at published and unpublished studies to assess the health risk to consumers from dietary exposure to pesticide residues in food.

(Editing by Gareth Jones)

Next In Health News

With eye on Obamacare, Price takes helm as U.S. health secretary

WASHINGTON Tom Price was sworn in as U.S. secretary of health on Friday, putting in place a determined opponent of Obamacare to help President Donald Trump fulfill his pledge to dismantle his predecessor's law and reshape the country's healthcare system.

Bird flu hits poultry markets in major Chinese city: media

BEIJING Authorities in China's third-largest city warned that about 30 percent of its live poultry markets were contaminated with the H7N9 avian flu virus, as an eastern province ordered markets to shut, state media reported on Saturday.

Venezuelan girl's diphtheria death highlights country's health crisis

PARIAGUAN, Venezuela Eliannys Vivas, 9, started to get a sore throat on a Friday last month in this languid Venezuelan town where papaya trees shade poor cinder-block homes.

MORE FROM REUTERS

Sponsored Content

From Around the WebPromoted by Revcontent

Trending Stories

    Pictures

    Photos of the week

    Sponsored Topics

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Careers

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertising Guidelines
    • Cookies
    • Terms of Use
    • Privacy Policy